JMP Securities Maintains Market Outperform on Seagen, Raises Price Target to $168
JMP Securities analyst Reni Benjamin maintains Seagen (NASDAQ:SGEN) with a Market Outperform and raises the price target from $142 to $168.
Why Boston Beer Shares Are Trading Lower By 13%? Here Are Other Stocks Moving In Thursday’s Mid-Day Session
Gainers
TravelCenters of America Inc. (NASDAQ: TA) shares jumped 70.5% to $84.32 after BP announced it will acquire the company for $86 per share in cash.
Analysts Are Bullish On Seagen’s Catalyst-Rich Pipeline, Finding No Problem With No M&A
Seagen Inc (NASDAQ:SGEN) reported a Q4 EPS loss of $(0.80), better than the consensus of $(1.05) and $(0.95) a year…
KBR, Twilio, Roku And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones dropping over 250 points on Thursday. Here are some big stocks recording gains in today’s session.
Needham Reiterates Buy on Seagen, Maintains $160 Price Target
Needham analyst Ami Fadia reiterates Seagen (NASDAQ:SGEN) with a Buy and maintains $160 price target.
HC Wainwright & Co. Reiterates Buy on Seagen, Maintains $180 Price Target
HC Wainwright & Co. analyst Andrew Fein reiterates Seagen (NASDAQ:SGEN) with a Buy and maintains $180 price target.
Evercore ISI Group Upgrades Seagen to Outperform, Raises Price Target to $175
Evercore ISI Group analyst Maneka Mirchandaney upgrades Seagen (NASDAQ:SGEN) from In-Line to Outperform and raises the price target from $140 to $175.
Seattle Genetics Q4 EPS $(0.80) Beats $(1.05) Estimate, Sales $528.15M Beat $480.15M Estimate
Seattle Genetics (NASDAQ:SGEN) reported quarterly losses of $(0.80) per share which beat the analyst consensus estimate of $(1.05) by 23.81 percent. This is a 15.79 percent increase over losses of $(0.95) per share from
Oppenheimer Maintains Outperform on Seagen, Lowers Price Target to $178
Oppenheimer analyst Jay Olson maintains Seagen (NASDAQ:SGEN) with a Outperform and lowers the price target from $188 to $178.
RH To Rally Over 15%? Here Are 10 Other Analyst Forecasts For Monday
Citigroup boosted the price target for RH (NYSE: RH) from $305 to $380. Citigroup analyst Steven Zaccone maintained a Buy rating. Hershey shares fell 4% to $330.00 in pre-market trading.